In English | En español
Questions About Cancer? 1-800-4-CANCER

Find a Cancer Type


NCI Vision & Priorities

The National Cancer Program
2013 Annual Plan and Budget Proposal
Provocative Questions Project
Explore provocative research questions with the research community
NCI Budget Overview
Explore how NCI allocates appropriated funds
Science Serving People
Research progress and NCI in your community

Popular Resources

Translucent plastic bag containing bevacizumab and other chemo drugs dripping through I.V. port

Bevacizumab Significantly Improves Survival for Patients With Advanced Cervical Cancer

Patients with advanced cervical cancer who received the drug bevacizumab (Avastin) lived a median 3.7 months longer than patients who did not receive the drug, according to interim results from a large, randomized clinical trial.